180 related articles for article (PubMed ID: 35151117)
1. A computational system for Bayesian benchmark dose estimation of genomic data in BBMD.
Ji C; Weissmann A; Shao K
Environ Int; 2022 Mar; 161():107135. PubMed ID: 35151117
[TBL] [Abstract][Full Text] [Related]
2. A Web-Based System for Bayesian Benchmark Dose Estimation.
Shao K; Shapiro AJ
Environ Health Perspect; 2018 Jan; 126(1):017002. PubMed ID: 29329100
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the lower limit of benchmark dose confidence interval with no-observed-adverse-effect level by applying four different software for tumorigenicity testing of pesticides in Japan.
Yasuhiko Y; Ishigami M; Machino S; Fujii T; Aoki M; Irie F; Kanda Y; Yoshida M
Regul Toxicol Pharmacol; 2022 Aug; 133():105201. PubMed ID: 35691450
[TBL] [Abstract][Full Text] [Related]
4. Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.
Shao K; Gift JS
Risk Anal; 2014 Jan; 34(1):101-20. PubMed ID: 23758102
[TBL] [Abstract][Full Text] [Related]
5. BMDExpress Data Viewer - a visualization tool to analyze BMDExpress datasets.
Kuo B; Francina Webster A; Thomas RS; Yauk CL
J Appl Toxicol; 2016 Aug; 36(8):1048-59. PubMed ID: 26671443
[TBL] [Abstract][Full Text] [Related]
6. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
Shao K; Zhou Z; Xun P; Cohen SM
Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
[TBL] [Abstract][Full Text] [Related]
7. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
8. A comparison of three methods for integrating historical information for Bayesian model averaged benchmark dose estimation.
Shao K
Environ Toxicol Pharmacol; 2012 Sep; 34(2):288-296. PubMed ID: 22647377
[TBL] [Abstract][Full Text] [Related]
9. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
[TBL] [Abstract][Full Text] [Related]
10. Benchmark dose modeling for epidemiological dose-response assessment using prospective cohort studies.
De Pretis F; Zhou Y; Xun P; Shao K
Risk Anal; 2024 Apr; 44(4):743-756. PubMed ID: 37496455
[TBL] [Abstract][Full Text] [Related]
11. Considerations for application of benchmark dose modeling in radiation research: workshop highlights.
Chauhan V; Yu J; Vuong N; Haber LT; Williams A; Auerbach SS; Beaton D; Wang Y; Stainforth R; Wilkins RC; Azzam EI; Richardson RB; Khan MGM; Jadhav A; Burtt JJ; Leblanc J; Randhawa K; Tollefsen KE; Yauk CL
Int J Radiat Biol; 2023; 99(9):1320-1331. PubMed ID: 36881459
[TBL] [Abstract][Full Text] [Related]
12. Potential uncertainty reduction in model-averaged benchmark dose estimates informed by an additional dose study.
Shao K; Small MJ
Risk Anal; 2011 Oct; 31(10):1561-75. PubMed ID: 21388425
[TBL] [Abstract][Full Text] [Related]
13. Using Prior Toxicological Data to Support Dose-Response AssessmentâIdentifying Plausible Prior Distributions for Dichotomous Dose-Response Models.
Shao K; Ji C; Chiu WA
Environ Sci Technol; 2022 Nov; 56(22):16506-16516. PubMed ID: 36279400
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Historical Data-Based Informative Prior on Benchmark Dose Estimation of Toxicogenomics.
Ji C; Shao K
Chem Res Toxicol; 2023 Aug; 36(8):1345-1354. PubMed ID: 37494567
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of transcriptomic datasets using benchmark dose modeling shows value in supporting radiation risk assessment.
Chauhan V; Adam N; Kuo B; Williams A; Yauk CL; Wilkins R; Stainforth R
Int J Radiat Biol; 2021; 97(1):31-49. PubMed ID: 32687419
[TBL] [Abstract][Full Text] [Related]
16. Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models.
Fang Q; Piegorsch WW; Simmons SJ; Li X; Chen C; Wang Y
Biometrics; 2015 Dec; 71(4):1168-75. PubMed ID: 26102570
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Risk Assessment: Developing a Bayesian Approach to Dichotomous Dose-Response Uncertainty.
Wheeler MW; Blessinger T; Shao K; Allen BC; Olszyk L; Davis JA; Gift JS
Risk Anal; 2020 Sep; 40(9):1706-1722. PubMed ID: 32602232
[TBL] [Abstract][Full Text] [Related]
18. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.
Davis JA; Gift JS; Zhao QJ
Toxicol Appl Pharmacol; 2011 Jul; 254(2):181-91. PubMed ID: 21034758
[TBL] [Abstract][Full Text] [Related]
19. Nonparametric Bayesian methods for benchmark dose estimation.
Guha N; Roy A; Kopylev L; Fox J; Spassova M; White P
Risk Anal; 2013 Sep; 33(9):1608-19. PubMed ID: 23339666
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional benchmark dose modeling: Exploring how advances in chemical risk assessment may be applied to the radiation field.
Chauhan V; Kuo B; McNamee JP; Wilkins RC; Yauk CL
Environ Mol Mutagen; 2016 Oct; 57(8):589-604. PubMed ID: 27601323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
